Releases - RaySearch Laboratories

View:
 

Found press releases

 

RaySearch Laboratories AB (publ) Interim Report January 1 – March 31, 2013

5/16/2013 1:45 AM EST
JANUARY 1 – MARCH 31, 2013

· Net sales for the period amounted to SEK 47.9 M (38.4)
· Profit after tax totaled SEK 5.2 M (4.6) and earnings per share was SEK 0.15 (0.13)
· Operating profit was SEK 8.1 M (6.7)
· Cash flow amounted to SEK 0.6 M (10.9)
· First orders for RayStation® from Spain and France
· RayStation® 3.5 released

AFTER THE END OF THE PERIOD

· RaySearch licensed technology from GSI
· Major...

RaySearch receives 510(k) clearance for RayStation® 3.5

5/15/2013 5:31 AM EST
In March RaySearch Laboratories AB announced that version 3.5 of RaySearch's RayStation® treatment planning system had been released for clinical use. RaySearch has now received 510(k) clearance from the FDA for RayStation® 3.5 meaning that the new features can be marketed in the US. 

The most important new features are state of-the-art tools for treatment planning of radiation therapy with electrons and protons,...

Invitation to Annual General Meeting 2013

4/22/2013 5:00 AM EST
The shareholders in RaySearch Laboratories AB (publ), corporate identity no. 556322-6157, are hereby invited to the Annual General Meeting on Wednesday 22 May, 2013, at 6:00 p.m., in Grünewaldsalen, Konserthuset, Stockholm, Sweden.

 RIGHT TO PARTICIPATE AND NOTICE

Shareholders who wish to participate in the Annual General Meeting and to have the right to vote, must:

-          be recorded in the share register...

Major treatment center in Maryland selects RayStation

4/22/2013 2:30 AM EST
The University of Maryland Marlene and Stewart Greenebaum Cancer Center has announced that they are implementing RayStation® to customize radiation therapy for cancer patients over the course of their treatment. The system will allow doctors to fine-tune the radiation dose and make other adjustments to the treatment plan as patients experience changes such as tumor shrinkage and/or weight loss.

“We are taking a...

RaySearch licenses technology from GSI

4/12/2013 3:47 AM EST
RaySearch Laboratories AB (publ.) has entered into a license agreement with GSI Helmholtzzentrum für Schwerionenforschung in Darmstadt, Germany (GSI) regarding techniques for calculating radiobiological effective dose in ion beam treatments.
Ion beam therapy is the most advanced form of external radiotherapy where the tumor is irradiated with protons or carbon ions. Compared to conventional radiotherapy, where...

Annual Report 2012

3/27/2013 4:34 AM EST
Annual Report 2012

RaySearch’s 2012 Annual Report Published

3/27/2013 4:00 AM EST
As of today, the 2012 Annual Report of RaySearch Laboratories AB (publ) is available in Swedish as a pdf file on the company’s website www.raysearchlabs.com. The printed version in Swedish is now under distribution to the shareholders. The English version is under production and will be finalized in conjunction with RaySearch’s Annual General Meeting on Wednesday, May 22, 2013. Printed annual reports can be ordered...

RayStation® 3.5 released

3/15/2013 4:42 AM EST
RaySearch Laboratories AB announces that version 3.5 of RaySearch's RayStation® treatment planning system has been released for clinical use in the European Union, USA, Japan and Australia, and is pending regulatory approval in Canada, China, New Zealand and South Korea. The new version includes a wide range of new features and improvements. 

With RayStation® 3.5 RaySearch releases state of-the-art tools for...

RaySearch Laboratories AB (publ) Year-end Report 2012

2/14/2013 1:45 AM EST
JANUARY 1 – DECEMBER 31, 2012

· Net sales for the year amounted to SEK 182.1 M (126.1)
· Profit after tax totaled SEK 19.9 M (17.0) and the result per share was of SEK 0.58 (0.50)
· Operating profit was SEK 22.5 M (27.6)
· Cash flow amounted to SEK 33.3 M (neg: 46.2)
· The first complete version of RayStation® was released in January and an additional new version in August.
· A total of 23 orders for...

First RayStation order in France

2/1/2013 3:00 AM EST
RaySearch Laboratories AB has received an order for its RayStation® treatment planning system from the Lucien Neuwirth Institute of Cancerology (ICLN – Institut de Cancérologie Lucien Neuwirth) in Saint Priest en Jarez, France.
ICLN is a public hospital specialized in cancer treatment and is part of the Saint Etienne University Campus. The institute offers state-of-the-art cancer treatments using chemotherapy...

RaySearch Laboratories

RSS

RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are sold through license agreements with leading partners su...

View more


  CONTACT